Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and response.

Literature DB >> 7437267

Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and response.

M Eichelbaum, M Albrecht, G Kliems, K Schäfer, A Somogyi.

Abstract

Entities: Chemical

Mesh：

Substances：
Verapamil

Year: 1980 PMID： 7437267 PMCID： PMC1430149 DOI： 10.1111/j.1365-2125.1980.tb01800.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

6 in total

1. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1976-10

2. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.

Authors: R Gugler; P Lain; D L Azarnoff
Journal: J Pharmacol Exp Ther Date: 1975-12 Impact factor: 4.030

Review 3. Drug kinetics and hepatic blood flow.

Authors: C F George
Journal: Clin Pharmacokinet Date: 1979 Nov-Dec Impact factor: 6.447

4. The disposition of propranolol. I. Elimination during oral absorption in man.

Authors: D G Shand; R E Rangno
Journal: Pharmacology Date: 1972 Impact factor: 2.547

5. Determination of verapamil in human plasma by mass fragmentography using stable isotope-labelled verapamil as internal standard.

Authors: B Spiegelhalder; M Eichelbaum
Journal: Arzneimittelforschung Date: 1977

6. Physiological disposition of verapamil in man.

Authors: M Schomerus; B Spiegelhalder; B Stieren; M Eichelbaum
Journal: Cardiovasc Res Date: 1976-09 Impact factor: 10.787

6 in total

13 in total

1. Effect of oral verapamil on glibenclamide stimulated insulin secretion.

Authors: C G Semple; C Omile; K D Buchanan; G H Beastall; K R Paterson
Journal: Br J Clin Pharmacol Date: 1986-08 Impact factor: 4.335

2. Effects of verapamil on exocrine pancreatic secretion in man.

Authors: C Niederau; A Hellmann; A Sonnenberg; J Erckenbrecht
Journal: Dig Dis Sci Date: 1985-01 Impact factor: 3.199

3. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.

Authors: G M Rubin; J A Waschek; S M Pond; D J Effeney; T N Tozer
Journal: J Pharmacokinet Biopharm Date: 1987-12

4. Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing. Studies with deuterated verapamil.

Authors: M Eichelbaum; A Somogyi
Journal: Eur J Clin Pharmacol Date: 1984 Impact factor: 2.953

Review 5. Application of stable labelled drugs in clinical pharmacokinetic investigations.

Authors: M Eichelbaum; G E von Unruh; A Somogyi
Journal: Clin Pharmacokinet Date: 1982 Nov-Dec Impact factor: 6.447

6. Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.

Authors: M Eichelbaum; A Somogyi; G E von Unruh; H J Dengler
Journal: Eur J Clin Pharmacol Date: 1981-01 Impact factor: 2.953